ImmunoGen, Inc.

IMGN Stock Healthcare Biotechnology
$31.23
+0.00 (+0.00%)
Price as of Oct 14, 2026 market close

Performance

1 Month
+0.0%
3 Months
+0.0%
YTD
+0.0%
1 Year
+116.4%
3 Year annualized
+29.3%
5 Year annualized
+39.6%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
87.0%
Largest decline max drawdown, last 5 years
-58.0%
Risk-adjusted return Sharpe ratio, 1-year
1.19

Own IMGN?

See how IMGN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.